I think the only thing that matters is does this product work safely and effectively in humans and still at this stage we don't know the answer as investors. desperately awaiting any indication that it is safe and effective.
Human trials were first announced back in April 2020 I believe and were booked at Cmax to avoid clashing with covid at hospitals and taking up space. We have updates that things are progressing well but really in simple terms what does that mean? Is it only days until first patient dosed with iv phase 1 or is it months away? Are burns patients about to be treated or is it months away? I know report said first patient this quarter but it appeared last quarter all was ready to go and approval given. Again just frustrated as I know it is no simple process to put an untested drug into humans but really until we have some form of human proof of efficacy for this product in humans the wait is becoming excrutiating.
- Forums
- ASX - By Stock
- RCE
- Ann: Further Encouraging COVID Results at Doherty
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Further Encouraging COVID Results at Doherty, page-33
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online